Shane Barton - 27 Sep 2024 Form 4 Insider Report for BioAge Labs, Inc. (BIOA)

Role
Principal Accounting Officer
Signature
/s/ Dov A. Goldstein as attorney-in-fact
Issuer symbol
BIOA
Transactions as of
27 Sep 2024
Net transactions value
+$47,376
Form type
4
Filing time
10 Mar 2025, 16:10:37 UTC
Previous filing
25 Sep 2024
Next filing
20 Dec 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIOA Common Stock Purchase $47,376 +2,632 $18.00 2,632 27 Sep 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported securities were purchased through a directed share program in connection with the Issuer's initial public offering.